Skip to main navigation

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Product Candidates
    • Pipeline
    • tivozanib
    • ficlatuzumab
    • av-203
    • av-380
    • av-353
  • publications & presentations
  • Media
    • Press Releases
    • Media Toolkit
  • Investors
    • Overview
    • Corporate Governance
    • Stock Information
    • Research Coverage
    • SEC Filings
    • Annual Reports
    • Press Releases
    • Scientific Publications & Presentations
    • Calendar of Events
    • FAQs
    • Information Request
  • Careers
    • Life at Aveo
    • Job Openings
  • Contact

Investors

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Product Candidates
    • Pipeline
    • tivozanib
    • ficlatuzumab
    • av-203
    • av-380
    • av-353
  • publications & presentations
  • Media
    • Press Releases
    • Media Toolkit
  • Investors
    • Overview
    • Corporate Governance
    • Stock Information
    • Research Coverage
    • SEC Filings
    • Annual Reports
    • Press Releases
    • Scientific Publications & Presentations
    • Calendar of Events
    • FAQs
    • Information Request
  • Careers
    • Life at Aveo
    • Job Openings
  • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Aug 8, 2019
Document Date
Jun 30, 2019
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
AVEO Oncology
Issuer
AVEO PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contacts
© 2021 AVEO Pharmaceuticals, Inc. All rights reserved.
Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Product Candidates
    • Pipeline
    • tivozanib
    • ficlatuzumab
    • av-203
    • av-380
    • av-353
  • publications & presentations
  • Media
    • Press Releases
    • Media Toolkit
  • Investors
    • Overview
    • Corporate Governance
    • Stock Information
    • Research Coverage
    • SEC Filings
    • Annual Reports
    • Press Releases
    • Scientific Publications & Presentations
    • Calendar of Events
    • FAQs
    • Information Request
  • Careers
    • Life at Aveo
    • Job Openings
  • Contact